Changes in the epidemiology and management of bacterial infections in cirrhosis

키워드

참고문헌 (63)

1. Jalan R, "Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013", J Hepatol, 60, pp.1310~1324 (2014)
2. Albillos A, "Cirrhosis-associated immune dysfunction : distinctive features and clinical relevance", J Hepatol, 61, pp.1385~1396 (2014)
3. Clària J, "Orchestration of tryptophan-kynurenine pathway, acute decompensation, and acute-on-chronic liver failure in cirrhosis", Hepatology, 69, pp.1686~1701 (2019)
4. Wiest R, "Pathological bacterial translocation in liver cirrhosis", J Hepatol, 60, pp.197~209 (2014)
5. Bajaj JS, "Altered profile of human gut microbiome is associated with cirrhosis and its complications", J Hepatol, 60, pp.940~947 (2014)
6. Huelin P, "Validation of a staging system for acute kidney injury in patients with cirrhosis and association with acute-on-chronic liver failure", Clin Gastroenterol Hepatol, 15, pp.438~445 (2017)
7. Merli M, "Increased risk of cognitive impairment in cirrhotic patients with bacterial infections", J Hepatol, 59, pp.243~250 (2013)
8. Moreau R, "Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis", Gastroenterology, 144, pp.1426~1437.E9 (2013)
9. Arvaniti V, "Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis", Gastroenterology, 139, pp.1246~1256.E5 (2010)
10. Trebicka J, "PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis", J Hepatol, 74, pp.1097~1108 (2021)
11. Schmidt ML, "Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010", Gastroenterology, 148, pp.967~977.e2 (2015)
12. Fernández J, "The challenges of multidrug-resistance in hepatology", J Hepatol, 65, pp.1043~1054 (2016)
13. Fernández J, "Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe", J Hepatol, 70, pp.398~411 (2019)
14. Fasolato S, "Renal failure and bacterial infections in patients with cirrhosis : epidemiology and clinical features", Hepatology, 45, pp.223~229 (2007)
15. Piano S, "Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide", Gastroenterology, 156, pp.1368~1380.e10 (2019)
16. Fernández J, "Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis : a prospective study", Hepatology, 55, pp.1551~1561 (2012)
17. Bartoletti M, "A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients", Clin Microbiol Infect, 24, pp.546.e1~546.e8 (2018)
18. Piano S, "Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections", Gut, 67, pp.1892~1899 (2018)
19. Merli M, "The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis : a prospective survey", PLoS One, 10, pp.e0127448~ (2015)
20. Tandon P, "High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center", Clin Gastroenterol Hepatol, 10, pp.1291~1298 (2012)
21. Bajaj JS, "Second infections independently increase mortality in hospitalized patients with cirrhosis : the North American consortium for the study of end-stage liver disease(NACSELD)experience", Hepatology, 56, pp.2328~2335 (2012)
22. Ariza X, "Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis", J Hepatol, 56, pp.825~832 (2012)
23. Cheong HS, "Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis", Clin Infect Dis, 48, pp.1230~1236 (2009)
24. Fernández J, "Bacterial infections in cirrhosis : epidemiological changes with invasive procedures and norfloxacin prophylaxis", Hepatology, 35, pp.140~148 (2002)
25. Reuken PA, "Emergence of spontaneous bacterial peritonitis due to enterococci-risk factors and outcome in a 12-year retrospective study", Aliment Pharmacol Ther, 35, pp.1199~1208 (2012)
26. Piano S, "Infections complicating cirrhosis", Liver Int, 1(Suppl 1), pp.126~133 (2018)
27. European Association for the Study of the Liver, "EASL clinical practice guidelines for the management of patients with decompensated cirrhosis", J Hepatol, 69, pp.406~460 (2018)
28. Bajaj JS, "Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures", Hepatology, 60, pp.250~256 (2014)
29. Wong F, "Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure", J Hepatol, 74, pp.330~339 (2021)
30. Arroyo V, "Acute-on-chronic liver failure", N Engl J Med, 382, pp.2137~2145 (2020)
31. Fernández J, "Bacterial and fungal infections in acute-on-chronic liver failure : prevalence, characteristics and impact on prognosis", Gut, 67, pp.1870~1880 (2018)
32. Angeli P, "Sepsis-induced acute kidney injury in patients with cirrhosis", Hepatol Int, 10, pp.115~123 (2016)
33. Piano S, "Why and how to measure renal function in patients with liver disease", Liver Int, 37(Suppl 1), pp.116~122 (2017)
34. Arabi YM, "Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis", Hepatology, 56, pp.2305~2315 (2012)
35. Piano S, "The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis : results of a randomized, controlled clinical trial", Hepatology, 63, pp.1299~1309 (2016)
36. Lutz P, "Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis", Eur J Clin Invest, 47, pp.44~52 (2017)
37. Kim SW, "Empirical treatment with carbapenem vs third-generation cephalosporin for treatment of spontaneous bacterial peritonitis", Clin Gastroenterol Hepatol, 19, pp.976~986 (2021)
38. Merli M, "An empirical broad spectrum antibiotic therapy in health-careassociated infections improves survival in patients with cirrhosis : a randomized trial", Hepatology, 63, pp.1632~1639 (2016)
39. Bartoletti M, "Continuous infusion of beta-lactam antibiotics in cirrhotic patients with bloodstream infection : results from a prospective multicentre observational study", J Hepatol, 68, pp.S44~S45 (2018)
40. Piano S, "Predictors of early readmission in patients with cirrhosis after the resolution of bacterial infections", Am J Gastroenterol, 112, pp.1575~1583 (2017)
41. Runyon BA, "Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100patients", Gastroenterology, 100, pp.1737~1742 (1991)
42. Sort P, "Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis", N Engl J Med, 341, pp.403~409 (1999)
43. Bernardi M, "Albumin in decompensated cirrhosis : new concepts and perspectives", Gut, 69, pp.1127~1138 (2020)
44. Guevara M, "Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study", J Hepatol, 57, pp.759~765 (2012)
45. Thévenot T, "Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial", J Hepatol, 62, pp.822~830 (2015)
46. Fernández J, "Efficacy of albumin treatment for patients with cirrhosis and infections unrelated to spontaneous bacterial peritonitis", Clin Gastroenterol Hepatol, 18, pp.963~973.e14 (2020)
47. Acevedo J, "Relative adrenal insufficiency in decompensated cirrhosis : relationship to short-term risk of severe sepsis, hepatorenal syndrome, and death", Hepatology, 58, pp.1757~1765 (2013)
48. Piano S, "Including relative adrenal insufficiency in definition and classification of acute-on-chronic liver failure", Clin Gastroenterol Hepatol, 18, pp.1188~1196.e3 (2020)
49. Jang JY, "Relative adrenal insufficiency in chronic liver disease : its prevalence and effects on long-term mortality", Aliment Pharmacol Ther, 40, pp.819~826 (2014)
50. Fernández J, "Adrenal insufficiency in patients with cirrhosis and septic shock : effect of treatment with hydrocortisone on survival", Hepatology, 44, pp.1288~1295 (2006)
51. Arabi YM, "Low-dose hydrocortisone in patients with cirrhosis and septic shock : a randomized controlled trial", CMAJ, 182, pp.1971~1977 (2010)
52. Fernández J, "Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis", Gastroenterology, 133, pp.818~824 (2007)
53. Moreau R, "Effects of long-term norfloxacin therapy in patients with advanced cirrhosis", Gastroenterology, 155, pp.1816~1827.e9 (2018)
54. Fernández J, "Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage", Gastroenterology, 131, pp.1049~1056 (2006)
55. Ginés P, "Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis : results of a double-blind, placebo-controlled trial", Hepatology, 12(4 Pt 1), pp.716~724 (1990)
56. Lontos S, "A randomized controlled study of trimethoprim-sulfamethoxazole versus norfloxacin for the prevention of infection in cirrhotic patients", J Dig Dis, 15, pp.260~267 (2014)
57. Kang SH, "Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy", Aliment Pharmacol Ther, 46, pp.845~855 (2017)
58. Reiberger T, "Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis", J Hepatol, 58, pp.911~921 (2013)
59. Senzolo M, "β-blockers protect against spontaneous bacterial peritonitis in cirrhotic patients : a meta-analysis", Liver Int, 29, pp.1189~1193 (2009)
60. O’Brien AJ, "Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2", Nat Med, 20, pp.518~523 (2014)
61. Caraceni P, "Long-term albumin administration in decompensated cirrhosis(ANSWER) : an open-label randomised trial", Lancet, 391, pp.2417~2429 (2018)
62. Di Pascoli M, "Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites", Liver Int, 39, pp.98~105 (2019)
63. Solà E, "Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial", J Hepatol, 69, pp.1250~1259 (2018)

관련 논문AI추천